- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 23, 2019
Politics & Policy
Aug. 23 P&P Quick Takes: FDA meetings on pediatric safety of OxyContin, Singulair; a vaccine meeting on Chikungunya
BioCentury | Dec 14, 2018
Clinical News
FDA issues complete response letter to NDA for Mallinckrodt pain therapy
BioCentury | Jul 28, 2017
Clinical News
Panel rejects Intellipharmaceutics' Rexista abuse deterrence claims
Items per page:
1 - 10 of 18